Alyssum Therapeutics

About:

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.

Website: https://www.alyssumtx.com/

Top Investors: Accel, Navam Capital, Famy Care, Patrick Soon-Shiong

Description:

Total Funding Amount:

$26M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-10-23

IPO Status:

Private

Industries: